Healthcare Brief Comoros
SEE OTHER BRANDS

Keeping up with health and wellness news from Comoros

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on July 31, 2025

Press release: Online availability of Sanofi’s half-year financial report for 2025

Press release: Online availability of Sanofi’s half-year financial report for 2025

Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorite …

Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi

Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi

Mise en ligne du rapport financier semestriel 2025 de Sanofi Paris, le 31 juillet 2025. Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son rapport financier semestriel au 30 juin …

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …

Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair  published in Hernia

Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia

Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that …

A Power Move Among Longevity Leaders: Global Longevity Summit and A4M Join Forces, Spearhead Definitive Event on the Life Extension Frontier

A Power Move Among Longevity Leaders: Global Longevity Summit and A4M Join Forces, Spearhead Definitive Event on the Life Extension Frontier

GENEVA, SWITZERLAND, July 31, 2025 (GLOBE NEWSWIRE) -- In a landmark strategic alliance, the Global Longevity Summit and the American Academy of Anti-Aging Medicine (A4M) have joined forces to launch a singular forum dedicated to harnessing the radical …

Accelerating Alzheimer’s Research: Groundbreaking Alzheimer's Disease Dataset Now Available to the Public

Accelerating Alzheimer’s Research: Groundbreaking Alzheimer's Disease Dataset Now Available to the Public

WASHINGTON, July 31, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) announced today that data generated from the Bio-Hermes-001 study are now publicly available. …

Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell Growth, Including New Evidence Against New Previously Untested KRAS Mutation

Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell Growth, Including New Evidence Against New Previously Untested KRAS Mutation

Grand Cayman, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …

ADR Ratio Change Effective

ADR Ratio Change Effective

July 31, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Effective ADSs Outstanding Post Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative …

Global Kombucha Market Set to Reach $5.9 Billion by 2029, Driven by Health and Wellness Trends

Global Kombucha Market Set to Reach $5.9 Billion by 2029, Driven by Health and Wellness Trends

Delray Beach, FL, July 31, 2025 (GLOBE NEWSWIRE) -- The global kombucha market is undergoing a significant transformation, propelled by rising consumer awareness and the increasing shift toward healthier beverage alternatives. According to a recent report …

CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer

CoRegen, Inc. Appoints Biotech Veteran Sonal Gupta, M.D., Ph.D., as Chief Medical Officer

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- CoRegen, a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointment of industry veteran Sonal Gupta, M.D., Ph.D., as …

Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology

Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology

MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ platform. This milestone reflects Elucent’s ongoing …

AIM ImmunoTech Announces Closing of $8.0 Million Public Offering

AIM ImmunoTech Announces Closing of $8.0 Million Public Offering

OCALA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the closing of its previously announced public offering of an aggregate of 2,000,000 shares of its common stock (or pre-funded warrants …

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no …

The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health

The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health

FRAMINGHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consultancy, today released its 2025 Biologics Contract Manufacturing Report, a comprehensive resource tracking the evolution of the global contract development and …

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use …

Little Leaves Behavioral Services Opens Two New Locations in Maryland

Little Leaves Behavioral Services Opens Two New Locations in Maryland

SILVER SPRING, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based Applied Behavior Analysis (ABA) services for preschool-aged autistic children, today announced the opening of two new Maryland …

Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China

Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory Bowel Disease is a large and growing …

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage …

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen to its Board of …

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions